Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

EMA Recommends Extension of Indications for Tafasitamab

Ogkologos - 4 Δεκεμβρίου, 2025

Aiming to Prevent Cancer Cases, ESMO Calls Against Misleading Alcohol-Labelling Following...

Ogkologos - 3 Δεκεμβρίου, 2025

FDA Approves New Interchangeable Biosimilar to Pertuzumab

Ogkologos - 3 Δεκεμβρίου, 2025

ESMO Call for Cancer Care Safeguards Reflected in the EU’s Health...

Ogkologos - 2 Δεκεμβρίου, 2025

EU Cancer Mission and Partners Launch First Cancer Mission Forum for...

Ogkologos - 2 Δεκεμβρίου, 2025

Patient Guide in Testicular Cancer Now Available Also in French

Ogkologos - 1 Δεκεμβρίου, 2025

Patient Guide in Bladder Cancer Now Available Also in Italian

Ogkologos - 28 Νοεμβρίου, 2025

Shaping Cancer Care in Asia: ESMO Brings Research and Patient Voices...

Ogkologos - 28 Νοεμβρίου, 2025

Adding Tucatinib to T-DM1 Improves PFS in Previously Treated HER2-positive Advanced...

Ogkologos - 28 Νοεμβρίου, 2025

FDA Grants Accelerated Approval to Sevabertinib for Non-Squamous NSCLC

Ogkologos - 27 Νοεμβρίου, 2025

1...313233...440 Σελίδα 32 από 440

MOST POPULAR

Pralsetinib: Measures to Minimise Increased Risk for Tuberculosis

25 Μαΐου, 2023

Analysis of the Gut Microbiome Provides Clues to Survival Following Nivolumab...

9 Ιουλίου, 2021

Impact of Multigene Germline Genetic Testing on Selection of Germline-Directed Therapy...

27 Αυγούστου, 2021

Pivotal Role of the Institutional Molecular Tumour Board in Evaluating the...

10 Σεπτεμβρίου, 2021

Φόρτωση περισσοτέρων

EMA Recommends Extension of Indications for Tafasitamab

Aiming to Prevent Cancer Cases, ESMO Calls Against Misleading Alcohol-Labelling Following...

FDA Approves New Interchangeable Biosimilar to Pertuzumab

ESMO Call for Cancer Care Safeguards Reflected in the EU’s Health...

EU Cancer Mission and Partners Launch First Cancer Mission Forum for...

Patient Guide in Testicular Cancer Now Available Also in French

Patient Guide in Bladder Cancer Now Available Also in Italian

Shaping Cancer Care in Asia: ESMO Brings Research and Patient Voices...

Adding Tucatinib to T-DM1 Improves PFS in Previously Treated HER2-positive Advanced...

FDA Grants Accelerated Approval to Sevabertinib for Non-Squamous NSCLC

MOST POPULAR

Pralsetinib: Measures to Minimise Increased Risk for Tuberculosis

Analysis of the Gut Microbiome Provides Clues to Survival Following Nivolumab...

Impact of Multigene Germline Genetic Testing on Selection of Germline-Directed Therapy...

Pivotal Role of the Institutional Molecular Tumour Board in Evaluating the...

HOT NEWS

Can Eating Grilled or Charred Foods Cause Cancer?

Emma Stone Motivated to Help Others After Her Mother Was Diagnosed...

EMA Recommends Extension of Indications for Acalabrutinib to Include the Treatment...

ESMO Calls for Cancer Care Integration in EU Global Health Resilience...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ